Frequently Asked Questions
-
What value is the shrimp disease diagnostics market expected to touch by 2027?
The global shrimp disease diagnostics market size is expected to reach USD 1466.09 million by 2027.
-
What CAGR is the shrimp disease diagnostics market expected to exhibit by 2027?
The shrimp disease diagnostics market is expected to exhibit a CAGR of 14.35% by 2027.
-
Which are the driving factors of the shrimp disease diagnostics market?
Drivers of this shrimp disease diagnostics market are growing need for shrimp farming and huge production of shrimps and the increased prevalence of viral infections in shrimps.
-
Which are the top companies operating in the shrimp disease diagnostics market?
GeneReach Biotechnology Corp., REAGEN LLC, Auro Biotechnologies, HiMedia Laboratories pop bio, AquaBounty Technologies, Inc., Lab - Ind Resource Sdn Bhd., FUJIKURA KASEI CO., LTD., Thermo Fisher Scientific, SUREBIO, and Speedy Assay Sdn Bhd are the top companies operating in the shrimp disease diagnostics market.